Moreover, in clinical samples of ovarian cancer, ERα is widely expressed, while the levels of ERβ expression are progressively lost during ovarian cancer progression toward metastatic tumors (Rutherford et al., 2000). The gene discussed is ESR1; the disease is ovarian carcinoma.